2 538

Cited 2 times in

Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma

DC Field Value Language
dc.contributor.author김도영-
dc.contributor.author김범경-
dc.contributor.author김승업-
dc.contributor.author김은혜-
dc.date.accessioned2014-12-18T08:46:18Z-
dc.date.available2014-12-18T08:46:18Z-
dc.date.issued2013-
dc.identifier.issn0954-691X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/86922-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAntineoplastic Agents/administration & dosage*-
dc.subject.MESHCarcinoma, Hepatocellular/therapy*-
dc.subject.MESHDrug Administration Schedule-
dc.subject.MESHHumans-
dc.subject.MESHLiver Neoplasms/therapy*-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNiacinamide/administration & dosage-
dc.subject.MESHNiacinamide/analogs & derivatives*-
dc.subject.MESHPhenylurea Compounds/administration & dosage*-
dc.subject.MESHRadiotherapy, Adjuvant-
dc.subject.MESHYttrium Radioisotopes/therapeutic use-
dc.titleOptimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorKim, Eun Hye-
dc.contributor.googleauthorKim, Beom Kyung-
dc.contributor.googleauthorKim, Do Young-
dc.contributor.googleauthorKim, Seung Up-
dc.identifier.doi10.1097/MEG.0b013e32835c04dd-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00487-
dc.contributor.localIdA00654-
dc.contributor.localIdA00827-
dc.contributor.localIdA00385-
dc.relation.journalcodeJ00821-
dc.identifier.eissn1473-5687-
dc.identifier.pmid23466449-
dc.identifier.urlhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00042737-201304000-00020&LSLINK=80&D=ovft-
dc.subject.keywordAntineoplastic Agents/administration & dosage*-
dc.subject.keywordCarcinoma, Hepatocellular/therapy*-
dc.subject.keywordDrug Administration Schedule-
dc.subject.keywordHumans-
dc.subject.keywordLiver Neoplasms/therapy*-
dc.subject.keywordMale-
dc.subject.keywordMiddle Aged-
dc.subject.keywordNiacinamide/administration & dosage-
dc.subject.keywordNiacinamide/analogs & derivatives*-
dc.subject.keywordPhenylurea Compounds/administration & dosage*-
dc.subject.keywordRadiotherapy, Adjuvant-
dc.subject.keywordYttrium Radioisotopes/therapeutic use-
dc.contributor.alternativeNameKim, Do Young-
dc.contributor.alternativeNameKim, Beom Kyung-
dc.contributor.alternativeNameKim, Seung Up-
dc.contributor.alternativeNameKim, Eun Hye-
dc.contributor.affiliatedAuthorKim, Beom Kyung-
dc.contributor.affiliatedAuthorKim, Seung Up-
dc.contributor.affiliatedAuthorKim, Eun Hye-
dc.contributor.affiliatedAuthorKim, Do Young-
dc.rights.accessRightsnot free-
dc.citation.volume25-
dc.citation.number4-
dc.citation.startPage514-
dc.citation.endPage515-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, Vol.25(4) : 514-515, 2013-
dc.identifier.rimsid32035-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.